Fox Hill Wealth Management’s Boston Scientific BSX Stock Holding History

Fox Hill Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,113	Closed	-$227K	–	126
2025 Q2	$227K	Buy	2,113 +37	+2%	+$3.74K	0.12%	97
2025 Q1	$209K	Buy	+2,076	New	+$209K	0.12%	93
2024 Q1	–	Sell	-4,046	Closed	-$234K	–	146
2023 Q4	$234K	Buy	+4,046	New	+$216K	0.18%	89

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fox Hill Wealth Management's BSX Position: Q3 2025 in Review

Fox Hill Wealth Management sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 2,113 shares — an estimated $227K sold.

Fox Hill Wealth Management first reported a position in BSX in Q4 2023 and held it in 3 quarters. The position peaked at $234K in Q4 2023. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

Fox Hill Wealth Management reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
Fox Hill Wealth Management sold 2,113 Boston Scientific shares in Q3 2025, an estimated $227K.
Fox Hill Wealth Management first reported a position in Boston Scientific in Q4 2023 and held it in 3 quarters.
Fox Hill Wealth Management's Boston Scientific position peaked at $234K in Q4 2023.
1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Fox Hill Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.